Gabapentin is an antiepileptic drug that is effective in treating seizures, neuropathies, and a variety of neurological and psychological maladies. Although designed as a gamma-aminobutyric acid (GABA) analogue, gabapentin does not bind to GABA receptors, nor does it affect the neuronal uptake or degradation of GABA. Administer orally 3 times daily without regard to meals. Interval between doses should not exceed 12 hours. If film-coated scored tablets containing 600 or 800 mg of gabapentin are divided to administer a 300- or 400-mg dose, use the remaining half tablet for the next dose. Discard half tablets that are not used within 28 days. In adult patients, the half-life of gabapentin is about 5 to 7 hours. In other words, it takes the body about 5 to 7 hours to eliminate its gabapentin concentration by half. This estimate can be altered by many factors including but not limited to kidney function. Pediatric Patients. Half-life for pediatric patients is roughly 4.7 hours. Half-life. The elimination t 1/2 of gabapentin in patients with normal renal function is 5-7 hours. 16,17,5 In patients with reduced renal function, the elimination t 1/2 may be prolonged - in patients with a creatinine clearance of 30 mL/min, the reported half-life of gabapentin was approximately 52 hours. 16,17. Clearance Gabapentin Half-Life. Gabapentin comes in immediate-release and extended-release formulations as a tablet. The half-life of gabapentin is between 5 and 7 hours, which is how long it takes for the drug’s concentration in the body to be reduced by half.[3] The liver is responsible for metabolizing most drugs, but gabapentin works differently. However, individuals with renal impairment experience higher plasma concentrations of gabapentin, as well as an increased elimination half-life. For example, one report documented that among 11 individuals with renal failure, just one 400 mg oral gabapentin dose had a half-life of 132 hours (on average). Gabapentin lasts between 6 and 8 hours per dose for most people. In general, it needs to be taken consistently for optimal effect. Neurontin (gabapentin) has a relatively short half-life and duration of action. Gabapentin enacarbil (brand name Horizant) is a prodrug of gabapentin that has been designed to overcome the limitations of gabapentin, such as poor absorption and a short duration of action. It requires hydrolyzation in the gastrointestinal tract to become active. Gabapentin belongs to the group of medicines known as anticonvulsants. 2. Upsides Subjects (N = 60) with renal impairment (mean creatinine clearance ranging from 13 to 114 mL/min) were administered single 400 mg oral doses of gabapentin. The mean gabapentin half-life ranged from about 6.5 hours (patients with creatinine clearance > 60 mL/min) to 52 hours (creatinine clearance < 30 mL/min) and gabapentin renal clearance from Infants 1 month to Children 12 years: 4.7 hours. Adults, normal: 5 to 7 hours; increased half-life with decreased renal function; anuric adult patients: 132 hours; adults during hemodialysis: 3.8 hours. <3% In CrCl <30 mL/minute, half-life is approximately 52 hours (immediate release). Gabapentin is eliminated from the systemic circulation by renal excretion as unchanged drug. Gabapentin is not appreciably metabolized in humans. Gabapentin elimination half-life is 5 to 7 hours and is unaltered by dose or following multiple dosing. Gabapentin elimination rate constant, plasma clearance, and renal clearance are directly *The dose is normalized to 1,000 mg equivalent (mg-eq) of gabapentin. t max is presented as median (minimum, maximum). b.i.d. = twice daily; q.d. = once daily; t.i.d. = 3 times daily; C max = maximum plasma concentration over the last dosing day; t max = time to reach maximum concentration over the dosing interval in which the C max was observed (if the maximum value occurred more than once in Knowing the gabapentin half-life can also be important regarding withdrawal, to know when withdrawal symptoms would occur. In general, half-life refers to the time it takes for the amount of drug present in the system to be reduced by 50%. After one half-life of gabapentin, its concentration in the body would be half the original dose. In adult patients, the half-life of gabapentin is about 5 to 7 hours. In other words, it takes the body about 5 to 7 hours to eliminate its gabapentin concentration by half. This estimate can be altered by many factors including but not limited to kidney function. Half-life for pediatric patients is roughly 4.7 hours. *Half-life is the time it takes for your body to metabolize half of the drug, and includes active metabolites (e.g., oxazepam is a metabolite of diazepam). ** Comparative Oral Dose: Since there is no standard, equivalencies vary between the sources. This table was compiled from the two sources shown in the table, and was checked against four In reality, the half-life of gabapentin varies from person to person, and even sometimes within the same person. The half-life of gabapentin can be affected by the following factors: Pre-existing conditions. See our article Drug Half-life Explained for more general information about half-lives. Peak plasma concentration: 9585 ng/mL (1800 mg qDay) AUC: 132,808 ng•hr/mL; Distribution. Protein bound: 3% Vd: 58 L. Metabolism. Gabapentin is not appreciably metabolized in humans. Not a substrate, inducer, or inhibitor of CYP450 isoenzymes. Elimination. Half-life: 5-7 hr. Dialyzable: Yes. Renal clearance: 225 mL/min; 125 mL/min (if older The mean gabapentin half-life ranged from about 6.5 hours (patients with creatinine clearance >60 mL/min) to 52 hours (creatinine clearance <30 mL/min) and gabapentin renal clearance from about 90 mL/min (>60 mL/min group) to about 10 mL/min (<30 mL/min). The mean gabapentin half-life ranged from about 6.5 hours (patients with creatinine clearance >60 mL/min) to 52 hours (creatinine clearance <30 mL/min) and gabapentin renal clearance from about 90 mL/min (>60 mL/min group) to about 10 mL/min (<30 mL/min). Gabapentin: Gabapentin is indicated for postherpetic neuralgia and serves as adjunctive therapy for managing partial seizures (with or without secondary generalization) in adults and pediatric patients aged 3 or older.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |